Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion of cash to creditors, subject ...
The Associated Press on MSN12d
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from SacklersMembers of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
Daily Voice on MSN12d
Purdue Pharma Files New $7.4B Bankruptcy Plan: How Opioid Victims, Families Could BenefitPurdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...
In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to grant a release and injunction that extinguishes direct claims against ...
WASHINGTON — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller ...
Purdue Pharma on Wednesday filed a new Chapter 11 reorganization plan with the U.S. Bankruptcy Court for the Southern District of New York to settle opioid-related claims involving the company for ...
Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback